For most diabetics, an age-old challenge has been the inability to lose weight despite workouts. For millions of others, tweaking their diet to get slimmer hasn’t produced much of a result. Now, a new class of weight-loss drugs that control glucose levels while cutting cravings is raising hope for folks facing these twin dilemmas. Wegovy (2.4mg) and Ozempic (1mg), injections administered once a week, are taking the world by storm. Medical
obesity: Tale of two anti-obesity drugs for diabetics: Does the euphoria signal an end to the chronic disease?
